FindTrial
Sign In

Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection in Patients with Non-small Cell Lung Cancer: A Retrospective Cohort Study

Effect of Interval Between Neoadjuvant therapy and Surgery on Clinical Outcomes of Patients with Non-small Cell Lung Cancer: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093714
Enrollment
Unknown
Registered
2024-12-10
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Short interval group:None
Intermediate interval group:None
Long interval group:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age greater than 18 years; 2. Biopsy pathologically confirmed non-small cell lung cancer; 3. Clinical stage I-III, no distant organ metastasis; 4. Complete cycle of neoadjuvant therapy before surgery; 5. Radical surgical resection.

Exclusion criteria

Exclusion criteria: 1. Received radiotherapy before surgery; 2. Complicated with other life-threatening serious organic diseases; 3. Previous lung cancer treatment, including surgery, chemotherapy, radiotherapy, targeted therapy or immunotherapy; 4. Complicated with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
disease-free survival;overall survival;—

Secondary

MeasureTime frame
pathologiacl response;perioperative data;—

Countries

China

Contacts

Public ContactZhang Hao

The Affiliated Hospital of Xuzhou Medical University

zhanghao@xzhmu.edu.cn+86 177 9883 5177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026